HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Koichi Hirata Selected Research

Immunotherapy

4/2017Cancer-associated oxidoreductase ERO1-α promotes immune escape through up-regulation of PD-L1 in human breast cancer.
12/2016Hypoxia augments MHC class I antigen presentation via facilitation of ERO1-α-mediated oxidative folding in murine tumor cells.
6/2015Delayed facial weakness in Guillain-Barré and Miller Fisher syndromes.
3/2013Reversible conduction failure is distinct from neurophysiological patterns of recovery in mild demyelinating Guillain-Barré syndrome.
1/2013Immunotherapeutic benefit of α-interferon (IFNα) in survivin2B-derived peptide vaccination for advanced pancreatic cancer patients.
11/2012[Human endoplasmic reticulum oxidoreductin 1-like α regulates immune response of cancer cells via modulation of major histocompatibility complex class I expression and oxidation].
7/2011Transcriptional regulation of claudin-18 via specific protein kinase C signaling pathways and modification of DNA methylation in human pancreatic cancer cells.
2/2011The feasibility of Cep55/c10orf3 derived peptide vaccine therapy for colorectal carcinoma.
8/2007Efficient cross-presentation by heat shock protein 90-peptide complex-loaded dendritic cells via an endosomal pathway.
10/2004[Anti-apoptosis protein, survivin-2B-derived peptide vaccine therapy].
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Koichi Hirata Research Topics

Disease

98Neoplasms (Cancer)
11/2021 - 01/2002
36Breast Neoplasms (Breast Cancer)
04/2017 - 03/2002
31Migraine Disorders (Migraine)
04/2024 - 10/2005
28Colorectal Neoplasms (Colorectal Cancer)
09/2018 - 01/2003
22Infections
04/2015 - 12/2002
21Pancreatic Neoplasms (Pancreatic Cancer)
08/2019 - 01/2002
21Neoplasm Metastasis (Metastasis)
09/2018 - 01/2002
21Stomach Neoplasms (Stomach Cancer)
07/2016 - 08/2002
19Guillain-Barre Syndrome
01/2018 - 01/2002
17Parkinson Disease (Parkinson's Disease)
05/2022 - 01/2007
17Pancreatitis
06/2015 - 01/2002
13Restless Legs Syndrome (Restless Legs)
12/2022 - 01/2010
12Headache (Headaches)
03/2024 - 10/2005
12Lymphatic Metastasis
10/2016 - 03/2003
12Miller Fisher Syndrome (Fisher Syndrome)
05/2013 - 04/2003
11Adenocarcinoma
08/2019 - 02/2005
11Hepatocellular Carcinoma (Hepatoma)
08/2018 - 10/2002
10Disorders of Excessive Somnolence (Hypersomnia)
05/2022 - 06/2002
10Carcinoma (Carcinomatosis)
03/2015 - 08/2002
10Colonic Neoplasms (Colon Cancer)
04/2014 - 06/2002
9Pain (Aches)
12/2022 - 11/2004
8Narcolepsy
04/2022 - 03/2002
8Cholangitis
01/2018 - 01/2006
8Liver Diseases (Liver Disease)
07/2014 - 07/2003
7Encephalitis (Encephalitis, Rasmussen)
05/2021 - 04/2004
7Multiple System Atrophy
01/2020 - 01/2008
6Wounds and Injuries (Trauma)
01/2021 - 03/2003
6Fibrosis (Cirrhosis)
01/2018 - 11/2007
6Hemorrhage
10/2017 - 10/2004
6Hypoxia (Hypoxemia)
12/2016 - 11/2009
6Reperfusion Injury
07/2014 - 02/2002
6Abdominal Pain (Pain, Abdominal)
01/2010 - 01/2002
5Stroke (Strokes)
04/2023 - 01/2007
5Infarction (Infarctions)
11/2021 - 02/2007
5Leukocytosis (Pleocytosis)
05/2020 - 05/2008
5Nervous System Diseases (Neurological Disorders)
04/2020 - 10/2007
5Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
01/2020 - 02/2014
5Obesity
09/2015 - 01/2007
5Liver Cirrhosis (Hepatic Cirrhosis)
10/2014 - 07/2006
5Gallstones (Gallstone)
08/2012 - 01/2006
5Ischemia
07/2007 - 02/2002
4Disease Progression
06/2019 - 11/2012
4Cataplexy
12/2018 - 03/2002
4Abscess
01/2018 - 01/2002
4Acute Cholecystitis
01/2018 - 01/2007

Drug/Important Bio-Agent (IBA)

31Proteins (Proteins, Gene)FDA Link
05/2020 - 10/2002
21AntibodiesIBA
03/2015 - 03/2002
17Peptides (Polypeptides)IBA
08/2019 - 06/2004
17Immunoglobulin G (IgG)IBA
11/2014 - 01/2002
15Biomarkers (Surrogate Marker)IBA
10/2020 - 07/2006
14Anti-Infective Agents (Microbicides)IBA
12/2014 - 12/2002
13Monoclonal AntibodiesIBA
04/2024 - 08/2002
13AntigensIBA
12/2016 - 05/2003
12Anti-Bacterial Agents (Antibiotics)IBA
01/2021 - 01/2002
10SurvivinIBA
08/2019 - 01/2004
10Fluorouracil (Carac)FDA LinkGeneric
09/2018 - 10/2002
9erenumabIBA
04/2024 - 11/2019
9Insulin (Novolin)FDA Link
06/2019 - 01/2002
9Cisplatin (Platino)FDA LinkGeneric
07/2016 - 12/2002
9GangliosidesIBA
07/2014 - 06/2003
9Complementary DNA (cDNA)IBA
01/2013 - 01/2002
8Indicators and Reagents (Reagents)IBA
06/2015 - 10/2004
7Tryptamines (Triptans)IBA
09/2023 - 10/2005
7Pramipexole (Mirapex)FDA LinkGeneric
11/2017 - 01/2010
7Messenger RNA (mRNA)IBA
01/2016 - 01/2002
6Calcitonin Gene-Related PeptideIBA
04/2024 - 01/2021
6OrexinsIBA
04/2022 - 03/2002
6SteroidsIBA
02/2020 - 01/2006
6Protein Subunit VaccinesIBA
08/2019 - 06/2004
6TegafurIBA
09/2018 - 01/2003
6EnzymesIBA
05/2015 - 12/2005
6Small Interfering RNA (siRNA)IBA
09/2013 - 10/2005
5HLA Antigens (Human Leukocyte Antigens)IBA
01/2022 - 02/2011
5Hormones (Hormone)IBA
11/2018 - 05/2003
5Oxidoreductases (Dehydrogenase)IBA
04/2017 - 11/2012
5ClaudinsIBA
10/2016 - 08/2010
5Docetaxel (Taxotere)FDA Link
07/2016 - 02/2009
5Claudin-4IBA
12/2015 - 09/2011
5AutoantibodiesIBA
11/2014 - 12/2005
5Cancer VaccinesIBA
01/2013 - 02/2005
5TamoxifenFDA LinkGeneric
04/2012 - 01/2003
4galcanezumabIBA
09/2023 - 06/2021
4fremanezumabIBA
01/2023 - 01/2021
4rotigotineFDA Link
05/2022 - 01/2013
4HLA-DQB1 antigen (HLA DQB1)IBA
01/2022 - 01/2015
4Glucose (Dextrose)FDA LinkGeneric
03/2020 - 05/2008
4GemcitabineFDA Link
08/2019 - 01/2008
4UracilIBA
09/2018 - 01/2003
4Leucovorin (Folinic Acid)FDA Link
09/2018 - 10/2009

Therapy/Procedure

55Therapeutics
10/2021 - 05/2002
32Drug Therapy (Chemotherapy)
04/2022 - 01/2002
17Hepatectomy
04/2015 - 05/2002
11Immunotherapy
04/2017 - 07/2003
5Aftercare (After-Treatment)
02/2024 - 05/2014
5Lymph Node Excision (Lymph Node Dissection)
10/2015 - 07/2007
5Critical Care (Surgical Intensive Care)
06/2015 - 01/2006
5Nutritional Support (Artificial Feeding)
06/2015 - 02/2004
5Lasers (Laser)
01/2012 - 10/2004
5Adjuvant Chemotherapy
07/2011 - 12/2002
4Length of Stay
01/2018 - 01/2006